9 Things These Women's Health Doctors Would Never Do
More, women's health just isn't as studied as men's health. Women largely weren't included in medical research and clinical trials until the early 1990s (yes, you read that right, only 30 years ago), which has caused gaps in knowledge when it comes to health treatments for women.
Now, there are entire practices and specialities that focus on the differences in health outcomes for women, and doctors who are passionate about furthering research.
We spoke with doctors who focus on various aspects of women's health about the health habits they avoid and what they wish all patients knew about their well-being. Here's what they'd never do:
'I'm moving all day long. And I think if everyone can make it a habit to just keep moving, our general health would be better in so many ways,' said Dr. Priya Freaney, a cardiologist and women's heart health specialist at Northwestern Medicine in Illinois. Freaney added that she stretches every day at a minimum to prep her body for a day of rushing around.
'I run a postpartum hypertension clinic where I see new moms who have had blood pressure or other heart problems during pregnancy, and I tell people that as new moms, you have to be kind of creative in where you get your movement because there's not a lot of time and there's a lot of other responsibility,' Freaney said.
Trying to fold in movement whenever you can is key, whether that's taking the stairs, going on stroller walks or walking instead of driving to your errands, she noted.
'Certainly compared to generations previous to us, we have more of an emphasis on exercise. Most people have sitting jobs, we spend most of our day sedentary, and we know that the biggest killer of women is heart disease, so as we get older, it becomes more and more important to protect our hearts, keep those arteries clear by doing things like exercising,' added Dr. Brintha Vasagar, a family physician in Wisconsin.
Exercise can also lessen feelings of anxiety and depression, help you sleep better and lowers the risk of certain cancers, including breast cancer.
All three experts told HuffPost that healthy eating is one of the pillars they stick to for their current health and future health. This means fresh foods and less meat for Dr. Clara Paik, the co-chief of the division of general obstetrics and gynecology at UC Davis Health in California.
Vasagar described diet as well-being 101 and said she limits processed foods and focuses on lean meats, fresh fruits and veggies.
Freaney said she follows an 80-20 rule, where 80% of the time she eats nutritious foods and the other 20% of the time she chooses foods that may not have a big nutritional benefit but are celebratory or joy-inducing.
Freaney also tries to limit bready sweets, overall, because of their high levels of cholesterol and saturated fats. She also cooks at home often and makes extra so she has easy, healthy meals throughout the week.
Both Vasagar and Freaney said it's important that you know your numbers — meaning, the factors that are generally checked through routine wellness and blood tests such as your blood pressure, blood sugar levels and cholesterol, in addition to your weight.
Many people wait until they have a problem to get their numbers checked, but that isn't the way to live a long, healthy life, noted Vasagar.
'It's those prevention strategies — knowing what your blood pressure is, knowing what your ideal weight should be for your body size, knowing what your sugars are and if you're at risk for diabetes — catching those things early,' Vasagar said.
Having high blood pressure and high cholesterol can put you at heightened risk of developing heart disease, but, lifestyle changes like diet and exercise can help get these numbers in a healthy range, and medication can help, too, noted Vasagar.
'That's why it's so important to know your numbers early, so you can do something about it, attack it and keep your health as optimal as possible for as long as possible,' Vasagar said.
As mentioned above, heart disease is the No. 1 killer of women in the United States — a fact that many people don't realize, said Freaney.
'Sixty million women in the United States have some form of heart disease and 80% of that is preventable to some degree,' Freaney noted.
'The common forms of heart diseases that can affect and ultimately kill women start early in life and accumulate silently in the body without us realizing it ... before they come to clinical significance, before we feel something that leads our doctors to discover it,' she said.
The earlier you can understand and address your heart disease risk factors (things like diabetes, high cholesterol, high blood pressure) the better, Freaney said.
'So, one piece of advice is that it is never too early for a woman to seek advice about their heart health,' she noted.
'I really tell people, and I myself, never douche or put something to cleanse your vagina,' Paik said.
'You're basically getting rid of the normal flora that's supposed to be there,' she said.
Flora is necessary for maintaining a healthy pH balance, maintaining a barrier against bacteria and fungal infections and more. So, disrupting it can cause problems.
'Women are extremely, almost too, hygienic in that area because they want to smell nice, and that's a particular area of concern,' Paik noted.
While lots of brands market lotions and soaps for the genital region, they aren't necessary or even safe. 'Just normal showering and washing with water is all you need to do in that area. You do not need to use soaps, perfumes, bath bombs, douching. I avoid any of that,' she said.
'For pregnant women, I always tell them to take prenatal vitamins,' Paik said.
'The folic acid in the prenatal vitamins is not the same as in multivitamins, it has an extra dose of folic acid, which is important for preventing spinal cord abnormalities in the baby,' she said.
People who are trying to get pregnant should also take prenatal vitamins, Paik said.
According to Freaney, pregnancy complications such as preeclampsia and gestational diabetes can put you at higher risk of heart disease later in life.
Research shows that people who had preeclampsia are at higher risk of stroke and those who had gestational diabetes are more likely to have heart artery calcification. This is true even if your blood sugar levels and other heart health markers go back to normal after pregnancy, Freaney noted.
'Individuals who have had pregnancies complicated by preeclampsia or gestational diabetes should have a proactive discussion with their doctors about how they can reduce their risk of heart disease,' Freaney said.
'Menopause is a big topic these days ... every woman is so different in terms of how they view and feel during menopause,' Paik said.
Some folks have hot flashes and night sweats for a few months while others are plagued with tough symptoms for years and years, she noted.
No matter how menopause impacts you, it isn't a time to throw your hands up and say 'oh well' or think you have to silently push through the discomfort. 'I, myself, just realized, 'Wow, this is the latter half of my life, I have one life to live. I better take good care of myself,'' Paik said.
'I really kicked into the nutrition and exercise and just trying to keep myself healthy, rather than dealing with illness once it happens,' she noted. And going on hormone treatment is also a good option for many women, Paik added.
'I know that estrogen has been a really hot topic, and that also is one of those things where our medical opinions on hormone replacement and the benefits and risks of estrogen have changed over time as we've gotten more information,' Vasagar said.
For a while, women strayed away from hormone treatments because of fears of breast cancer risk, Vasagar noted.
'Now, I think we're starting to get back into how can we use hormones to benefit women, protecting their heart health, protecting from osteoporosis, while also mitigating any risk that each individual has towards breast cancer and some other things that estrogen can contribute to,' Vasagar said.
Not only does menopause bring hot flashes, mood changes and bone density loss, it also brings negative changes to heart health.
'There's a big shift that happens there. We lose our natural estrogen levels, and with the loss of natural estrogen, our whole cardiometabolic profile shifts for the worst,' Freaney said.
'I try to counsel my female patients that the years around menopause are really a time of accelerating cardiovascular risk, and we need to go into that decade of life in the most optimal cardiovascular health to brace ourselves for this transition that is going to inevitably come to every woman,' she said.
Around menopause, your blood pressure increases, your LDL cholesterol (also known as the bad cholesterol) goes up and your HDL cholesterol (your good cholesterol) goes down, according to Freaney. Your fat mass goes up while your muscle mass goes down, she added. Your sleep and mood worsens, too, which can have downstream effects on exercise and nutrition — because who wants to go for a bike ride after a night of bad sleep?
'There's a whole batch of things that happen together that, when taken in full, create an overall riskier cardiovascular environment for a woman,' Freaney said.
'A lot of this people don't realize it's going to happen, and so they haven't gone into the menopausal years optimizing for it,' she noted. If you can focus on strength training to build muscle mass and setting good cardiovascular exercise habits and nutrition habits, you'll be more equipped to handle these changes and counteract them, Freaney said.
And, this is true no matter if you're in menopause, post-menopausal or pre-menopausal — it's never too early or late to make a change.
We're Gen X Doctors. Here Are The 5 Rules We Swear By For Longevity.
Depression Symptoms May Look Different For Black Women. Here's How.
7 Things You'd Be Shocked People Don't Know About Menopause
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Palm Beach physician pioneering new advances in ALS and inflammatory disease treatment
A Palm Beach physician-scientist is leading efforts to create breakthrough treatments for Parkinson's, ALS, Alzheimer's and other diseases through a biotech company she established nearly a decade ago. Dr. Simrit Parmar, a Northwestern University-trained oncologist and research scientist, launched Cellenkos Inc., in 2016 to accelerate the clinical development of "T regulatory cell" therapies for the treatment of autoimmune diseases and inflammatory disorders. T regulatory cells, or Tregs (pronounced tee-regs), are natural immune system regulator cells that suppress the activity of other immune cells to prevent excessive inflammation and autoimmune reactions. Before launching Cellenkos, Parmar conducted extensive research on these cells and developed therapies based on them. While working as an oncologist/hematologist in the Department of Stem Cell Transplantation and Cellular Therapy at the University of Texas's MD Anderson Cancer in Houston in 2009, she developed treatments using T regulatory cells derived from umbilical cord blood to help prevent graft-versus-host disease (GVHD), a complication that can occur after an allogeneic stem cell or bone marrow transplant. Parmar told the Daily News it was 'very discouraging' to watch patients die from GVHD, which motivated her to focus her research on controlling the inflammation caused by donor cells, starting with the discovery of T regulatory cells. As she continued to conduct her research, she discovered that these cells had uses beyond preventing GVHD. "We found that the application of these cells is beyond just that one niche," she told the Daily News. "It can be applied to any autoimmune disease, to any inflammatory disorder." In 2016, the cell technology Parmar developed at MD Anderson was licensed to Cellenkos, which now supports her ongoing research through a sponsored research agreement. Since then, Parmar has focused on her work advancing targeted Treg cell therapies designed to ease inflammation and regulate immune function. Cellenkos is currently in clinical trials for various inflammatory and autoimmune diseases, including ALS, bone marrow failure, severe COVID-19 and myelofibrosis. Results have been positive so far, Parmar said, noting that ALS patients have seen a delay in disease progression and functional decline and an improvement in quality of life. "We have made some great strides in neurodegenerative disease," she said. "We just published a paper in the New England Journal of Medicine Evidence on ALS, where we showed not only disease halting, but slight improvement in resolving inflammation. That research has applications beyond just ALS. We are hoping as we are garnering more funding, we can go after Parkinson's, Alzheimer's and multiple sclerosis." Inflammation is the root cause of many diseases including cardiac, respiratory, neurological and hematological disorders, Parmar said, and it also drives many autoimmune diseases. Parmar's cell therapies restore immune balance by targeting harmful T cells — a type of white blood cell called lymphocytes — that can mistakenly attack healthy cells in the body, and retraining the body's own defense mechanisms. "We have a drug that heals inside out," she said. "We believe that we neutralize the bad player, which may not have initiated the inflammation, but definitely plays a key role in the propagation of widespread inflammation." Parmar, a mother of three who lives in Palm Beach's North End and travels regularly to Houston, where Cellenkos is based, said she remains committed to developing cell therapies targeting a broad range of autoimmune and inflammatory diseases. Cellenkos is pursuing funding for larger ALS research studies in the U.S., and it is also preparing for the next phase of clinical trials required for federal Food and Drug Administration approval. Parmar said she sees Palm Beach County's emergence as a neuroscience hub as a key benefit of her move, and she hopes it will lead to new research, development, and partnership opportunities. "We're incredibly excited about the momentum building in the Palm Beach and Jupiter area around neuroscience innovation," she said. "With new opportunities for R&D collaboration in the region, it presents an ideal environment for us to expand. We see great potential not only to develop a manufacturing facility for neurological compounds … but also to establish a dedicated treatment center that brings these breakthroughs directly to patients.' Jodie Wagner is a journalist at the Palm Beach Daily News, part of the USA TODAY Florida Network. You can reach her at jwagner@ This article originally appeared on Palm Beach Daily News: Palm Beach physician-scientist pioneering groundbreaking ALS therapy
Yahoo
16 minutes ago
- Yahoo
Whoa—Scientists Found a Part of Human Cells We Never Knew Existed
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Here's what you'll learn when you read this story: Hemifusomes are fused vesicles, or sacs of fluid, that were previously unknown to exist inside cells. They were discovered using cryo-electron tomography, which literally freezes them in time, and confirmed to be actual organelles and not just background noise. Because hemifusomes collect and recycle junk proteins, they could mean more effective treatments for diseases caused and aggravated by protein plaque buildup, such as Alzheimer's. Back in high school biology, most of us learned about the innards of a cell, or its organelles, from ribosomes to mitochondria to the endoplasmic reticulum, and probably had to identify them on our midterms. Now, an unexpected discovery will probably soon rewrite those textbooks. The hemifusome is the new organelle that high school students (much to their chagrin) will have to remember. Biophysicist Seham Ebrahim of the University of Virginia and her team of researchers were observing mammalian cells when they discovered hemifusomes, which previously eluded detection because they are even smaller than mitochondria and can easily blur or be mistaken for background noise. These nano-orbs, which look like they have, noses bear an uncanny resemblance to BB-8 or the profiles of certain Muppets. Pop culture references aside, their function of organizing, cleaning up, and recycling proteins could potentially unlock new treatments for genetic and neurodegenerative diseases. Hemifusomes consist of two vesicles, which are membrane sacs filled with liquid and formed by hemifusion, meaning that the smaller of the two is fused to the larger one like a hemisphere, almost as if its other half is missing. This occurs when the outer layers of two membranes merge first while the inner membrane layers stay open until a thin connection between them forms a new vesicle. The attached vesicles are sometimes found on the outside of the organelle and sometimes on the inside, and though where exactly these vesicles originate is still unknown, hemifusomes are thought to facilitate the formation of new vesicles that transport materials throughout the cell. This is probably how they take out cellular trash. Ebrahim used cryo-electron tomography, or cryo-ET, to observe and image hemifusomes. The cells, which were kept at cryogenic temperatures, were imaged in two dimensions using an electron microscope. Superfast cameras then took multiple photos of the frozen cells and their organelles. From these photos, single images were created using algorithms, upgrading the 2D images to 3D. 'Our observation of hemifusomes in four different cell lines originating from various species and tissues and frozen as close as possible to their native state suggests that they may be common components of the cell periphery in a wide range of cells and tissues,' she said in a study recently published in Nature Communications. Something else the researchers wanted to explore was what kind of relationship hemifusomes had with endosomes, which are vesicles that transport extracellular material into the cell via the process of endocytosis. The cell's plasma membrane will fold inward to surround matter, such as food molecules, in the surrounding fluid. These molecules are then taken in by the cell, whose plasma membrane pinches off to create an endosome that carries them into the cytoplasm. Endosomes can also form through the fusion of vesicles that already exist within the cell. Ebrahim traced the activity of endosomes and hemifusomes, but they did not appear to work together. What makes hemifusomes so important is how they collect and recycle junk proteins. Many studies have shown that the buildup of protein plaque in the brain can cause and aggravate neurodegenerative diseases such as dementia and Alzheimer's, and more understanding about how these organelles operate could lead to the development of treatments that work with them. 'Future research should focus on determining whether hemifusomes and compound hemifusomes are present in other cellular regions,' Ebrahim said, 'and on elucidating the molecular mechanisms underlying their formation, stability, and function, as well as their broader implications for cellular physiology and pathology.' You Might Also Like The Do's and Don'ts of Using Painter's Tape The Best Portable BBQ Grills for Cooking Anywhere Can a Smart Watch Prolong Your Life?
Yahoo
18 minutes ago
- Yahoo
Sirtex Medical's SIR-Spheres® Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma
Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma and metastatic colorectal cancer WOBURN, Mass., July 7, 2025 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of interventional oncology solutions, today announced that the U.S. Food and Drug Administration (FDA) approved SIR-Spheres® Y-90 resin microspheres for the treatment of unresectable hepatocellular carcinoma (HCC) in the United States. With this approval, SIR-Spheres® is the only radioembolization therapy approved for the treatment of both metastatic colorectal cancer (mCRC) of the liver and HCC in the U.S. HCC is the most common form of liver cancer in adults in the U.S., according to the American Cancer Society. Radioembolization–commonly referred to as selective internal radiation therapy (SIRT)–with SIR-Spheres® uses personalized dosimetry to deliver the optimal dose of radiation directly to tumors in patients with HCC. This approval gives clinicians expanded flexibility in selecting a liver-directed therapy that aligns with patient-specific needs and treatment goals. "The expanded indication makes SIR-Spheres® the only Y-90 treatment approved in the U.S. for both HCC and mCRC," said Matt Schmidt, CEO of Sirtex. "This milestone reflects our ongoing commitment to delivering flexible, personalized therapies—with multiple dose options available daily—that empowers physicians to treat patients when and where it works best." This regulatory milestone is supported by results from the DOORwaY90 study, a prospective, multicenter, open-label clinical trial evaluating the safety and efficacy of SIR-Spheres® in treating HCC. The study enrolled 100 patients across 18 U.S. centers, with 65 patients included in the interim primary efficacy cohort. DOORwaY90 met its prespecified co-primary endpoints, demonstrating a best overall response rate (ORR) of 98.5% as assessed by independent central review. All evaluable patients demonstrated a response, indicating a 100% local tumor control rate. Additionally, the median duration of response (DoR) exceeded 300 days. These findings highlight SIR-Spheres® as a highly effective liver-directed therapy with a favorable safety profile. "This study moves the field of radioembolization forward with reproducible dosimetry outcomes and a strong safety profile linked to very positive clinical results," said Dr. Armeen Mahvash, Interventional Radiologist at MD Anderson Cancer Center and Co-Principal Investigator of the DOORwaY90 Study. "This will give multidisciplinary care teams the confidence to recommend SIR-Spheres® for HCC treatment." For more information and details on how to incorporate SIR-Spheres® into your practice, please contact Sirtex at info-use@ About SIR-Spheres®SIR-Spheres® Y-90 resin microspheres are indicated for the local tumor control of unresectable hepatocellular carcinoma (HCC) in patients with no macrovascular invasion, Child-Pugh A cirrhosis, well-compensated liver function, and good performance status. They are also indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy (IHAC) of FUDR (Floxuridine). Caution: Federal (USA) law restricts this device for sale by or on the order of a physician. Consult the Instructions for Use ( for a complete listing of indications, contraindications, side effects, warnings and precautions. About SirtexSirtex Medical is a global healthcare company focused on advancing minimally invasive, liver-directed cancer and embolization therapies. With offices in the U.S., Australia, Europe, and Asia, Sirtex delivers innovative interventional oncology and embolization solutions to physicians and patients worldwide. The company's lead product, SIR-Spheres® Y-90 resin microspheres, is now the only FDA approved product in the United States indicated for both the treatment of hepatocellular carcinoma (HCC) and metastatic colorectal cancer (mCRC). For more information, visit APM-US-010-06-25 View original content: SOURCE Sirtex Medical Inc. Sign in to access your portfolio